Serum testosterone and prostate-specific antigen levels are major risk factors for prostatic volume increase among benign prostatic hyperplasia patients
1998 ◽
Vol 30
(5)
◽
pp. 581-585
◽
2012 ◽
Vol 05
(05)
◽
1997 ◽
Vol 158
(6)
◽
pp. 2188-2192
◽
2013 ◽
Vol 54
(11)
◽
pp. 750
◽
1996 ◽
Vol 78
(3)
◽
pp. 409-413
◽
Serum Prostate Specific Antigen Levels During Hyperthermia Treatment of Benign Prostatic Hyperplasia
1990 ◽
Vol 144
(6)
◽
pp. 1388-1389
◽
2012 ◽
Vol 413
(5-6)
◽
pp. 561-567
◽